What is your regimen of choice for metastatic papillary renal cell carcinoma?

Answer from: Medical Oncologist at Academic Institution

My regimen of choice for papillary RCC is cabozantinib given recent evidence. Papillary renal cancer has not had a standard established therapy until recently. Most of the clinical trials in kidney cancer restricted eligibility to clear cell carcinoma component. SWOG 1500 reported results of a rando...

Comments

Medical Oncologist at University Medical Oncology
Thank you!! How do you feel about cabozantinib/niv...

Medical Oncologist at Dana-Farber Cancer Institute
Given the SWOG 1500 trial showing activity of cabo...

Medical Oncologist at Loyola University Chicago Stritch School of Medicine
Just a quick update to @Ulka N. Vaishampayan's ter...

Medical Oncologist at NYU Langone Medical Center
In metastatic renal papillary responding to PDL1 i...

Answer from: Medical Oncologist at Community Practice

I have had a few papillary patients I have put on nivo cabo with surprisingly little fuss from insurance. Extrapolating data that each of them are individually effective in papillary. The problem I run into is what to do at progression, perhaps lenvatinib, or axitinib, or maybe even TiVo in this set...

Please select the option that best describes you:

What is your regimen of choice for metastatic papillary renal cell carcinoma?

Related Questions